This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
Dublin: 14 °C Sunday 21 July, 2019

Irish company to produce medical device invented at UL

The device will help improve success rates in angioplasty procedures.

Ray Blowick and Dr Michael Walsh with the device.
Ray Blowick and Dr Michael Walsh with the device.
Image: Press 22

A MEDICAL DEVICE which was invented at University of Limerick is to be produced and brought to market by a company in Galway.

The device will be used to improve success rates in angioplasty procedures, which involve widening a narrowed or obstructed blood vessel. One of the risks of the procedure can be that particles of fatty deposits can be dislodged during the treatment. If they then block other arteries they pose a risk of a stroke or a heart attack to the patient.

Dr Michael Walsh, lead inventor of the device, said:

The device combines angioplasty balloon and embolic protection technologies allowing for continuous blood flow during the procedure. In practice this means the angioplasty balloon can be left in a full inflated state in the artery for a longer time than is currently possible. This will increase the efficiency of the angioplasty procedure and offers significant potential as a platform for drug-device combinations.

Clada Medical, based in Mervue Industrial Park in Galway city, has been licensed to produce the device. Its CEO Ray Blowick said the license was “very important for the future of our company” and that he expected it to help with the creation of new jobs and increasing exports in the biomedical industry here.

The device was created at the Centre for Applied Biomedical Engineering Research (CABER) at UL. There are around 1 million angioplasty procedures performed in the world every year.

  • Share on Facebook
  • Email this article

About the author:

Read next: